---
authors:
- Torro, John
- Bhayani, Azmina
category: Clinical Review
clinical_significance: High
external_resources:
- title: PubMed Entry
  type: reference
  url: https://pubmed.ncbi.nlm.nih.gov/38227882/
file_path: 2024/01/norgestrel-0-075-mg-opill-for-contraception.md
issue: '1'
keywords:
- Norgestrel
- Humans
- Contraception
last_updated: '2025-07-30'
mesh_terms:
- Humans
- Norgestrel
- Contraception
original_format: PubMed
pages: 90-91
patient_population: Adults
peer_reviewed: true
pmid: '38227882'
processed_date: '2025-07-30'
publication_date: '2024-01-01'
pubmed_enriched: true
pubmed_enriched_date: '2025-08-10'
reading_time_minutes: 5
source: American family physician
specialty:
- Family Medicine
status: processed
tags:
- pubmed-enhanced
- clinical-review
- clinical-medicine
- family-practice
title: Norgestrel 0.075 mg (Opill) for Contraception.
topics:
- Family Medicine
volume: '109'
publication_types: &id001
- Journal Article
pubmed_content_enriched: true
pubmed_full_data:
  pmid: '38227882'
  title: Norgestrel 0.075 mg (Opill) for Contraception.
  authors:
  - last_name: Torro
    fore_name: John
    initials: J
    affiliation: Lawrence Family Medicine Residency, Lawrence, Massachusetts.
  - last_name: Bhayani
    fore_name: Azmina
    initials: A
    affiliation: Lawrence Family Medicine Residency, Lawrence, Massachusetts.
  journal_info:
    title: American family physician
    iso_abbreviation: Am Fam Physician
    volume: '109'
    issue: '1'
  publication_info:
    year: '2024'
    month: '01'
    full_date: '2024-01-01'
  article_ids: {}
  mesh_terms:
  - descriptor: Humans
    major_topic: false
  - descriptor: Norgestrel
    major_topic: true
  - descriptor: Contraception
    major_topic: true
  publication_types: *id001
related_articles:
- pmid: '38227882'
  title: Norgestrel 0.075 mg (Opill) for Contraception.
  authors:
  - name: Torro J
    authtype: Author
    clusterid: ''
  - name: Bhayani A
    authtype: Author
    clusterid: ''
  source: Am Fam Physician
  pubdate: 2024 Jan
- pmid: '38346681'
  title: Norgestrel (Opill) Is the First Over-the-Counter Oral Contraceptive Pill
    Approved in the United States.
  authors:
  - name: Shiroff J
    authtype: Author
    clusterid: ''
  source: Nurs Womens Health
  pubdate: 2024 Apr
- pmid: '37682700'
  title: Opill - an OTC oral contraceptive.
  authors: []
  source: Med Lett Drugs Ther
  pubdate: 2023 Sep 18
- pmid: '2227068'
  title: Hormonal postcoital contraception with an ethinylestradiol-norgestrel combination
    and two danazol regimens.
  authors:
  - name: Zuliani G
    authtype: Author
    clusterid: ''
  - name: Colombo UF
    authtype: Author
    clusterid: ''
  - name: Molla R
    authtype: Author
    clusterid: ''
  source: Eur J Obstet Gynecol Reprod Biol
  pubdate: 1990 Dec
- pmid: '987891'
  title: Contraception with d-norgestrel silastic rods. Plasma levels of d-norgestrel
    and influence on the ovarian function.
  authors:
  - name: Weiner E
    authtype: Author
    clusterid: ''
  - name: Johansson ED
    authtype: Author
    clusterid: ''
  source: Contraception
  pubdate: 1976 Nov
---

# Norgestrel 0.075 mg (Opill) for Contraception.

**Authors:** Torro, John, Bhayani, Azmina

**Published in:** American family physician | Vol. 109, No. 1 | 2024-01-01

**Links:** [PubMed](https://pubmed.ncbi.nlm.nih.gov/38227882/)

## Clinical Information

**Population:** Adults | **Clinical Significance:** High

## Topics & Specialties

**Specialties:** Family Medicine

**Topics:** Family Medicine

## MeSH Terms

Humans, Norgestrel, Contraception

## Article Content

*Full article content to be extracted and formatted from source material.*

## Additional Resources

- [PubMed Entry](https://pubmed.ncbi.nlm.nih.gov/38227882/) (reference)

---

*Processed: 2025-07-30* | *PubMed Enhanced: 2025-07-30*
